Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

Form 8.3 - The Vanguard Group, Inc.: Tritax Big Box REIT PLC
Form 8.3 - The Vanguard Group, Inc.: Tritax Big Box REIT PLC
Form 8.3 - The Vanguard Group, Inc.: Tritax Big Box REIT PLC
Form 8.3 - The Vanguard Group, Inc.: Network International Holdings PLC
Form 8.3 - The Vanguard Group, Inc.: Network International Holdings PLC
Form 8.3 - The Vanguard Group, Inc.: Network International Holdings PLC
Form 8.3 - The Vanguard Group, Inc.: Mondi PLC
Form 8.3 - The Vanguard Group, Inc.: Mondi PLC
Form 8.3 - The Vanguard Group, Inc.: Mondi PLC
Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group PLCPhoto, wide shot, wide-angle lens, soft focus,  Reinsurance company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-bSRc7PrRT00tZTDNf9SggMTD.png?st=2023-05-06T18%3A48%3A49Z&se=2023-05-06T20%3A48%3A49Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-06T00%3A38%3A49Z&ske=2023-05-07T00%3A38%3A49Z&sks=b&skv=2021-08-06&sig=3seGuy7NQJX9RXUOWr6XArANokWXlKqwnEJxEHfdbSY%3D
Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group PLC
Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group PLC
Form 8.3 - The Vanguard Group, Inc.: Virgin Money UK PLCPhoto, wide shot, wide-angle lens, soft focus,  Asset management firm, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-4Gf80r47YD589EFtjlMy4oXE.png?st=2023-05-06T14%3A52%3A24Z&se=2023-05-06T16%3A52%3A24Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-06T00%3A39%3A24Z&ske=2023-05-07T00%3A39%3A24Z&sks=b&skv=2021-08-06&sig=d8x8qxYEsZ8AfRwcBw8eUkxkNQFVf9GobJgEag27Xug%3D
Form 8.3 - The Vanguard Group, Inc.: Virgin Money UK PLC
Form 8.3 - The Vanguard Group, Inc.: Virgin Money UK PLC
EQS-Adhoc: KATEK SE: KATEK intends to enter into a delisting agreement with Kontron Acquisition GmbH
EQS-Adhoc: KATEK SE: KATEK intends to enter into a delisting agreement with Kontron Acquisition GmbH
EQS-Adhoc: KATEK SE: KATEK intends to enter into a delisting agreement with Kontron Acquisition GmbH
Funding Circle Plc: DSH-Director/PDMR Shareholding*
Funding Circle Plc: DSH-Director/PDMR Shareholding*
Funding Circle Plc: DSH-Director/PDMR Shareholding*
thyssenkrupp nucera Selected for $50 Million Grant from the U.S. Department of Energy
thyssenkrupp nucera Selected for $50 Million Grant from the U.S. Department of Energy
thyssenkrupp nucera Selected for $50 Million Grant from the U.S. Department of Energy
Q&A on NB Private Equity Partners (NBPE): Offsetting higher interest rates, leaving return targets unchanged
Q&A on NB Private Equity Partners (NBPE): Offsetting higher interest rates, leaving return targets unchanged
Q&A on NB Private Equity Partners (NBPE): Offsetting higher interest rates, leaving return targets unchanged
EQS-News: Mainz Biomed: Webinar on Early Detection of Colorectal Cancer - Exploring New Laboratory Diagnostic Options
EQS-News: Mainz Biomed: Webinar on Early Detection of Colorectal Cancer - Exploring New Laboratory Diagnostic Options
EQS-News: Mainz Biomed: Webinar on Early Detection of Colorectal Cancer - Exploring New Laboratory Diagnostic Options
EQS-Adhoc: aap Implantate AG: Capital increase from authorized capital with exclusion of subscription rights
EQS-Adhoc: aap Implantate AG: Capital increase from authorized capital with exclusion of subscription rights
EQS-Adhoc: aap Implantate AG: Capital increase from authorized capital with exclusion of subscription rights
R.E.A. Holdings plc: Dividend payment in respect of 9 per cent cumulative preference sharesPhoto, wide shot, wide-angle lens,  Restaurant, sunset photo at golden hour, photo by Thomas Heaton: https://img.theapi.app/temp/57273392-070f-46de-9297-125616327242.png
R.E.A. Holdings plc: Dividend payment in respect of 9 per cent cumulative preference shares
R.E.A. Holdings plc: Dividend payment in respect of 9 per cent cumulative preference shares
EQS-Adhoc: ELARIS AG resolves to carry out a capital increase for cash from authorised capital with the exclusion of subscription rights in April 2024
EQS-Adhoc: ELARIS AG resolves to carry out a capital increase for cash from authorised capital with the exclusion of subscription rights in April 2024
EQS-Adhoc: ELARIS AG resolves to carry out a capital increase for cash from authorised capital with the exclusion of subscription rights in April 2024
R.E.A. Holdings plc: Further re further investment by DSN in REA KaltimPhoto, wide shot, wide-angle lens,  Supermarket, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.theapi.app/temp/12c4d93c-5c0e-4e39-8e32-e47404ce9d79.png
R.E.A. Holdings plc: Further re further investment by DSN in REA Kaltim
R.E.A. Holdings plc: Further re further investment by DSN in REA Kaltim
EQS-News: Formycon and Fresenius Kabi reach settlement agreement for ustekinumab biosimilar candidate FYB202 in Europe and CanadaPhoto, wide shot, wide-angle lens, soft focus,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-pKgbwxVSbyTCu0UzPNe8NL8D.png?st=2023-05-04T16%3A02%3A58Z&se=2023-05-04T18%3A02%3A58Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T12%3A13%3A51Z&ske=2023-05-05T12%3A13%3A51Z&sks=b&skv=2021-08-06&sig=%2BhYssNp3W0HiZMxCV64XVELyP8stYUjFhgUVfPrTLyg%3D
EQS-News: Formycon and Fresenius Kabi reach settlement agreement for ustekinumab biosimilar candidate FYB202 in Europe and Canada
EQS-News: Formycon and Fresenius Kabi reach settlement agreement for ustekinumab biosimilar candidate FYB202 in Europe and Canada
Turkiye Garanti Bankasi A.S.: Announcement regarding Fitch RatingsPhoto, wide shot, wide-angle lens, soft focus,  Asset management firm, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-4Gf80r47YD589EFtjlMy4oXE.png?st=2023-05-06T14%3A52%3A24Z&se=2023-05-06T16%3A52%3A24Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-06T00%3A39%3A24Z&ske=2023-05-07T00%3A39%3A24Z&sks=b&skv=2021-08-06&sig=d8x8qxYEsZ8AfRwcBw8eUkxkNQFVf9GobJgEag27Xug%3D
Turkiye Garanti Bankasi A.S.: Announcement regarding Fitch Ratings
Turkiye Garanti Bankasi A.S.: Announcement regarding Fitch Ratings
EQS-News: STAIDIUM U.S. and CALUVA Partner to Level the Playing Field in Sports RecruitingPhoto, wide shot, wide-angle lens, soft focus,  Movie theater, sunset photo at golden hour, photo by Marc Adamus: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-gXhfb5xMEy8zG0qLmxYAOaHt.png?st=2023-05-14T13%3A29%3A06Z&se=2023-05-14T15%3A29%3A06Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-14T01%3A25%3A03Z&ske=2023-05-15T01%3A25%3A03Z&sks=b&skv=2021-08-06&sig=cyWAC06qXhBJ4kv4K4eQVNNwtdGGK962uEjAh4%2B61ZY%3D
EQS-News: STAIDIUM U.S. and CALUVA Partner to Level the Playing Field in Sports Recruiting
EQS-News: STAIDIUM U.S. and CALUVA Partner to Level the Playing Field in Sports Recruiting
EQS-News: Ernst Russ AG: Positive business performance in 2023Photo, wide shot, wide-angle lens,  Private equity firm, sunset photo at golden hour, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/11edc0a6-edfc-46d1-baee-abd4f510abd1.png
EQS-News: Ernst Russ AG: Positive business performance in 2023
EQS-News: Ernst Russ AG: Positive business performance in 2023
EQS-News: Hannover Re appoints Thorsten Steinmann to the Executive Board to succeed Michael Pickel, who will retirePhoto, wide shot, wide-angle lens, soft focus,  Underwriting company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-N0Y6W7kvQQgUHnb7hSHO9TTV.png?st=2024-05-14T11%3A36%3A30Z&se=2024-05-14T13%3A36%3A30Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2024-05-13T19%3A10%3A46Z&ske=2024-05-14T19%3A10%3A46Z&sks=b&skv=2021-08-06&sig=1qvKLOloU0OWrpqzcuH7YcgBv7QI0hAOq2gAtJGiGqs%3D
EQS-News: Hannover Re appoints Thorsten Steinmann to the Executive Board to succeed Michael Pickel, who will retire
EQS-News: Hannover Re appoints Thorsten Steinmann to the Executive Board to succeed Michael Pickel, who will retire
Cairn Homes Plc: Transaction in Own SharesPhoto, wide shot, wide-angle lens,  Home appliance manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/5d70b6df-fa9b-4237-9702-39c36cb1d4f8.png
Cairn Homes Plc: Transaction in Own Shares
Cairn Homes Plc: Transaction in Own Shares
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Bedrock conditions in Finnish mine project idealPhoto, wide shot, wide-angle lens,  Coal mine, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/25526de2-54da-40ae-ba56-1e25dead3e81.png
Bedrock conditions in Finnish mine project ideal
Bedrock conditions in Finnish mine project ideal
EQS-News: Hannover Re beats full-year earnings target and raises dividend Photo, wide shot, wide-angle lens, soft focus,  Risk management company, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-vkrXsXVXnZepYEkiT4BvjtCA.png?st=2023-05-14T13%3A27%3A43Z&se=2023-05-14T15%3A27%3A43Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-14T00%3A09%3A01Z&ske=2023-05-15T00%3A09%3A01Z&sks=b&skv=2021-08-06&sig=y1VhH4rrtYGKSVOHO3rBwhpmvE42GCwp7%2BKdLaLI7kA%3D
EQS-News: Hannover Re beats full-year earnings target and raises dividend
EQS-News: Hannover Re beats full-year earnings target and raises dividend
EQS-News: LPKF receives major customer order in solar Photo, wide shot, wide-angle lens, soft focus,  Networking equipment supplier, sunset photo at golden hour, photo by Art Wolfe: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-LvyAFCAMshu3rGBke5G5gxuI.png?st=2023-05-10T15%3A37%3A29Z&se=2023-05-10T17%3A37%3A29Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-10T02%3A36%3A27Z&ske=2023-05-11T02%3A36%3A27Z&sks=b&skv=2021-08-06&sig=nXxCmLby4SxAAd/YtNVxZStdXrs9BCydapQDQaR/oac%3D
EQS-News: LPKF receives major customer order in solar
EQS-News: LPKF receives major customer order in solar
EQS-News: Heidelberg Pharma announces progress into Cohort 6 with its proprietary ATAC candidate HDP-101 in Phase I/IIa multiple myeloma studyPhoto, wide shot, wide-angle lens, soft focus,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-d5U47McddROtnUwv1JIaZvc2.png?st=2023-05-04T16%3A11%3A57Z&se=2023-05-04T18%3A11%3A57Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T16%3A04%3A37Z&ske=2023-05-05T16%3A04%3A37Z&sks=b&skv=2021-08-06&sig=KvGLXJQj4L2uYw31IYBsPpHX4telRq/7natMW2uEF58%3D
EQS-News: Heidelberg Pharma announces progress into Cohort 6 with its proprietary ATAC candidate HDP-101 in Phase I/IIa multiple myeloma study
EQS-News: Heidelberg Pharma announces progress into Cohort 6 with its proprietary ATAC candidate HDP-101 in Phase I/IIa multiple myeloma study